These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24867138)

  • 1. Comparison of therapeutic response to gonadotropin therapy between chinese male adolescents and young adults with hypogonadotropic hypogonadism caused by pituitary stalk interruption.
    Wang Q; Jiang W; Li G; Tang L; Hu Y
    Horm Metab Res; 2014 Aug; 46(9):668-73. PubMed ID: 24867138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
    Zacharin M; Sabin MA; Nair VV; Dabadghao P
    Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.
    Shimon I; Lubina A; Gorfine M; Ilany J
    J Androl; 2006; 27(3):358-64. PubMed ID: 16474013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
    Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
    Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Male hypogonadism in children and adolescents: diagnostic assessment and therapy indications].
    Braggion F; Gargantini L; Calzi P; Chiumello G
    Pediatr Med Chir; 1989; 11(6):577-82. PubMed ID: 2699924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of adult-onset idiopathic hypogonadotropic hypogonadism presenting with infertility].
    Terao H; Ogawa T; Yanagisawa M; Miyake M; Sano F; Kita K; Murakami T; Makiyama K; Nakaigawa N; Uemura H; Yao M; Kubota Y
    Hinyokika Kiyo; 2009 Jul; 55(7):437-9. PubMed ID: 19673435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the optimal therapy for young males with hypogonadotropic hypogonadism?
    Han TS; Bouloux PM
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):731-7. PubMed ID: 19912242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty.
    Wilson DA; Hofman PL; Miles HL; Unwin KE; McGrail CE; Cutfield WS
    J Pediatr; 2006 Jan; 148(1):89-94. PubMed ID: 16423605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypogonadotropic hypogonadism: new identification of testicular blood flow and varicocele after treatment with gonadotropins.
    ur Rehman K; Shahid K; Humayun H
    Fertil Steril; 2014 Sep; 102(3):700-704.e1. PubMed ID: 24934486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated hypogonadotropic hypogonadism in adolescence: Do we need to measure the pituitary, stalk or other imaging markers? A retrospective magnetic resonance imaging study.
    Ayaz E; Yıldırım R; Çelebi C; Özalkak Ş
    Turk J Pediatr; 2023; 65(3):445-455. PubMed ID: 37395964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Micropump infusion of gonadorelin in the treatment of hypogonadotropic hypogonadism in patients with pituitary stalk interruption syndrome: cases analysis and literature review].
    Shao WM; Bai WJ; Chen YM; Liu L; Wang YJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):642-5. PubMed ID: 25131486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study.
    Miyagawa Y; Tsujimura A; Matsumiya K; Takao T; Tohda A; Koga M; Takeyama M; Fujioka H; Takada S; Koide T; Okuyama A
    J Urol; 2005 Jun; 173(6):2072-5. PubMed ID: 15879837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.
    Petak SM; Nankin HR; Spark RF; Swerdloff RS; Rodriguez-Rigau LJ;
    Endocr Pract; 2002; 8(6):440-56. PubMed ID: 15260010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism.
    Finkel DM; Phillips JL; Snyder PJ
    N Engl J Med; 1985 Sep; 313(11):651-5. PubMed ID: 3927163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of preceding androgen therapy on testicular response to human pituitary gonadotropin in hypogonadotropic hypogonadism: a study of three patients.
    Burger HG; de Kretser DM; Hudson B; Wilson JD
    Fertil Steril; 1981 Jan; 35(1):64-8. PubMed ID: 7461155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal therapy of male hypogonadism.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of idiopathic hypogonadotropic hypogonadism.
    King TF; Hayes FJ
    Curr Opin Endocrinol Diabetes Obes; 2012 Jun; 19(3):204-10. PubMed ID: 22499222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
    Cisternino M; Manzoni SM; Coslovich E; Autelli M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male reproductive endocrinology: when to replace gonadotropins.
    Trussell JC
    Semin Reprod Med; 2013 Jul; 31(4):237-44. PubMed ID: 23775378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testicular responsiveness following chronic administration of hCG (1500 IU every six days) in untreated hypogonadotropic hypogonadism.
    Balducci R; Toscano V; Casilli D; Maroder M; Sciarra F; Boscherini B
    Horm Metab Res; 1987 May; 19(5):216-21. PubMed ID: 3583230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.